Atlas FDA

PerClot Polysaccharide Hemostatic System

FDA premarket approval P210036/S004 · decided 2024-07-18

Approval details

PMA number
P210036
Supplement
S004
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
PerClot Polysaccharide Hemostatic System
Generic name
Agent, absorbable hemostatic, non-collagen based
Applicant
Baxter Healthcare Corporation
Date received
2024-06-21
Decision date
2024-07-18
Days to decision
27 days
Decision code
OK30
Product code
LMG
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Round Lake, IL
Statement
for a change to the existing PerClot Dichloroacetate (‘DCA’) test methodology to allow for a detection limit of DCA residuals

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Welch Allyn FlexiPort Blood Pressure Cuffs (FlexiPort Blood Pressure Cuffs) (K251745)Baxter Healthcare Corporation2025-12-16
SIGMA Spectrum Infusion Pump with Master Drug Library (K251640)Baxter Healthcare Corporation2025-07-28
Spectrum IQ Infusion System with Dose IQ Safety Software (3570009) (K251636)Baxter Healthcare Corporation2025-07-28
Solution Administration Sets (K243529)Baxter Healthcare Corporation2025-03-14
Intravascular Extension Sets and Accessories (K242339)Baxter Healthcare Corporation2025-02-28
Novum IQ Syringe Pump (40800BAXUS) (K242390)Baxter Healthcare Corporation2024-09-05
Actifuse ABX; Actifuse MIS; Actifuse Shape; ALTAPORE; ALTAPORE SHAPE; ALTAPORE MIS (K241564)Baxter Healthcare Corporation2024-08-02
Novum IQ Large Volume Pump (K211122)Baxter Healthcare Corporation2024-03-29